GEA A/S Denmark   Report issue

For profit Phase 4
Founded: Düsseldorf Germany (1881)
Status: Left NME R&D (2011)

Organization Overview

First Clinical Trial
2001
NCT02280057
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1